A 5-day-old female neonate born to a 32-year-old primigravida mother presents with severe jaundice. The infant was born at term with a birth weight of 3.5 kg via cesarean section for cephalopelvic disproportion. Antenatal ultrasound at 28 weeks showed polyhydramnios. On examination, the baby is hydropic with hepatosplenomegaly, ascites, and generalized edema. Serum bilirubin is 22 mg/dL (total), with direct bilirubin 0.8 mg/dL. Direct Coombs test is strongly positive. Maternal blood group is O negative, and the infant's blood group is B positive. Hemoglobin is 9.2 g/dL with a reticulocyte count of 12%. What is the most appropriate initial management?

Explanation

## Clinical Diagnosis and Management: Rh Incompatibility with Hydrops Fetalis ### Clinical Presentation Analysis **Key Point:** This case represents severe Rh incompatibility (erythroblastosis fetalis) with hydrops fetalis—a medical emergency requiring immediate exchange transfusion. ### Diagnostic Features | Feature | Finding | Significance | |---------|---------|-------------| | **Maternal Blood Group** | O negative | Rh-negative mother (sensitized) | | **Infant Blood Group** | B positive | Rh-positive antigen on RBCs | | **Coombs Test** | Strongly positive | Heavy IgG coating of RBCs | | **Antenatal History** | Polyhydramnios at 28 weeks | Marker of fetal compromise | | **Clinical Signs** | Hydrops (edema, ascites, hepatosplenomegaly) | Severe hemolysis with cardiac failure | | **Hemoglobin** | 9.2 g/dL (low) | Significant anemia from hemolysis | | **Reticulocyte Count** | 12% (elevated) | Compensatory erythropoiesis | | **Bilirubin Level** | 22 mg/dL at day 5 | Exceeds exchange threshold | | **Direct Bilirubin** | 0.8 mg/dL (low) | Unconjugated hyperbilirubinemia | ### Pathophysiology of Rh Disease **High-Yield:** Rh incompatibility develops when: 1. Rh-negative mother becomes sensitized (usually during first pregnancy or delivery) 2. Maternal IgG anti-D antibodies develop and cross placenta in subsequent pregnancies 3. Antibodies bind to fetal D antigen on RBCs 4. Hemolysis occurs in fetal circulation → anemia, hyperbilirubinemia, hydrops 5. Severe cases cause fetal/neonatal death without intervention **Mnemonic: HYDROPS** — **H**emolysis, **Y**ellowness (jaundice), **D**istress (respiratory), **R**eticulocytosis, **O**edema, **P**leural effusion, **S**plenomegaly ### Why Exchange Transfusion Is Indicated **Clinical Pearl:** Exchange transfusion is the definitive treatment for severe neonatal jaundice with hemolysis because it: 1. **Removes bilirubin** — exchanges 80–90% of circulating bilirubin 2. **Removes sensitized RBCs** — eliminates RBCs coated with maternal antibodies 3. **Corrects anemia** — replaces destroyed RBCs with healthy donor RBCs 4. **Prevents kernicterus** — rapidly lowers unconjugated bilirubin before it crosses blood-brain barrier 5. **Treats hydrops** — improves cardiac output and tissue perfusion ### Blood Selection for Exchange Transfusion in Rh Disease **Key Point:** In Rh incompatibility, use **Rh-negative, type O blood** because: - **Rh-negative:** Lacks D antigen, so maternal anti-D antibodies cannot bind and cause further hemolysis - **Type O:** Universal donor RBCs; lacks A and B antigens, avoiding transfusion reactions - **Crossmatched:** Blood is crossmatched against both maternal and infant serum - **Fresh:** Preferably less than 5 days old to ensure optimal RBC survival and function ### Exchange Transfusion Procedure ```mermaid flowchart TD A[Severe Jaundice + Hemolysis]:::outcome --> B{Bilirubin exceeds exchange threshold?}:::decision B -->|Yes| C[Prepare for exchange transfusion]:::action C --> D[Obtain Rh-negative, type O blood]:::action D --> E[Establish umbilical venous catheter]:::action E --> F[Withdraw 5-10 mL blood aliquots]:::action F --> G[Infuse donor blood aliquots]:::action G --> H[Repeat until 2 blood volumes exchanged]:::action H --> I[Post-exchange monitoring]:::action I --> J[Check bilirubin at 4-6 hours]:::action J --> K{Bilirubin rebounding?}:::decision K -->|Yes| L[Repeat exchange if needed]:::action K -->|No| M[Continue phototherapy]:::action M --> N[Discharge when safe]:::outcome ``` ### Why Other Options Are Inadequate **Phototherapy alone (Option A):** - Insufficient for bilirubin level of 22 mg/dL at day 5 - Cannot remove sensitized RBCs or correct anemia - Risk of kernicterus in severely hemolyzed infants - Hydrops fetalis requires urgent intervention beyond phototherapy **IVIG followed by phototherapy (Option C):** - IVIG is adjunctive therapy, not primary treatment for severe Rh disease - May be used to reduce hemolysis rate, but does not replace exchange transfusion - Indicated when phototherapy alone is insufficient but not as first-line in hydrops - Slower onset of action than exchange transfusion **Packed RBC transfusion (Option D):** - Does not remove bilirubin or sensitized RBCs - Increases viscosity and worsens cardiac strain in hydrops - May precipitate hyperkalemia and cardiac arrhythmias - Not appropriate for unconjugated hyperbilirubinemia ### High-Yield Clinical Pearls **High-Yield:** - **Rh disease is preventable:** Antenatal RhIG (500 IU/kg at 28 weeks) reduces sensitization risk - **Postnatal RhIG:** Given to unsensitized Rh-negative mothers within 72 hours of delivery - **Hydrops fetalis:** Indicates severe fetal compromise; intrauterine transfusion may be needed prenatally - **Exchange transfusion threshold:** Varies by postnatal age and risk factors; use nomogram - **Kernicterus risk:** Highest in hemolytic disease due to rapid bilirubin rise and RBC destruction ### Prognosis and Follow-up **Clinical Pearl:** With appropriate exchange transfusion: - Bilirubin levels drop rapidly (by 50% or more) - Anemia improves as donor RBCs circulate - Hydrops may resolve over hours to days - Long-term prognosis is excellent if kernicterus is prevented - Subsequent pregnancies require antenatal monitoring and possible intrauterine transfusion [cite:Nelson Textbook of Pediatrics 21e Ch 101]